Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials-Reference-Cited by-同舟云学术

Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials

Published:2015-04 Issue:16 Volume:65 Page:1668-1682
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kelly Jacob P.,Mentz Robert J.,Mebazaa Alexandre,Voors Adriaan A.,Butler Javed,Roessig Lothar,Fiuzat Mona,Zannad Faiez,Pitt Bertram,O’Connor Christopher M.,Lam Carolyn S.P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference96 articles.

1. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association;Go;Circulation,2014

2. Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction;Tate;J Biomed Res,2014

3. Clinical epidemiology of heart failure: public and private health burden;McMurray;Eur Heart J,1998

4. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

5. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes;Steinberg;Circulation,2012

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxygen–ozone therapy for myocardial ischemic stroke and cardiovascular disorders;Medical Gas Research;2024-08-31

2. Heart Failure With Preserved Ejection Fraction in the Elderly Population: Basic Mechanisms and Clinical Considerations;Canadian Journal of Cardiology;2024-08

3. Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry;J CARDIOL;2024

4. Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction;Reviews in Cardiovascular Medicine;2024-07-23

5. Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction;ESC Heart Failure;2024-07-10